ANDA 208999, held by Sunshine. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 208999 (Metformin Hydrochloride), held by Sunshine, was first approved by FDA on Oct 12, 2018, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 12, 2018 | Original application | Approved | None posted |
| Metformin Hydrochloride500MG · tablet;oral | Metformin Hydrochloride | Discontinued |
| Metformin Hydrochloride850MG · tablet;oral | Metformin Hydrochloride | Discontinued |
| Metformin Hydrochloride1GM · tablet;oral | Metformin Hydrochloride | Discontinued |
| Aug 11, 2026 | Supplement 2Labeling · Standard review | Approved | None posted |
| Oct 12, 2018 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters